Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Rosetta signs microRNA diagnostic test agreement UC Irvine

Rosetta Genomics : 15 April, 2008  (Company News)
Rosetta Genomics has signed an agreement with University of California, Irvine School of Medicine (UC Irvine), relating to the development and validation of diagnostic tests based on the company's microRNA technology.
The tests are designed to differentiate squamous versus non-squamous lung cancer, differentiate mesothelioma from adenocarcinoma, and identify cancers of unknown primary (CUP) origin.

'This agreement is key to the successful implementation of our business strategy for our diagnostic products,' noted Amir Avniel, president and chief executive officer of Rosetta Genomics. 'With its experienced research team and state-of-the-art CLIA-certified laboratory, UC Irvine is an excellent collaborator for tests developed applying our microRNA technology.'

'We believe this agreement is an important step towards bringing microRNA-based diagnostics to patients and physicians,' said Dr John Krolewski, from UC Irvine. 'There is a large body of research into the significant potential microRNAs hold as powerful biomarkers, and we are excited to develop and validate assays using Rosetta Genomics' microRNA technology.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo